Summary of findings table ‐ Topical small molecule inhibitors (ruxolitinib) vs placebo
Health‐related quality of life ‐ not reported · adults with alopecia areata
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found